Blood proteins could reveal clues to prostate cancer risk more than a decade before diagnosis
Researchers at Oxford Population Health have identified specific blood proteins that may predict prostate cancer risk more than a decade before diagnosis. The study, which analyzed over 6,000 proteins in nearly 1,000 men, highlights biological markers that could help identify aggressive forms of the disease earlier.
Why it matters
This discovery could lead to more effective, early-stage screening tools for prostate cancer, potentially improving survival rates for the most common cancer in men.
edited by Sadie Harley , reviewed by Robert Egan
This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility:
Add to Preferred Sources Credit: CC0 Public Domain Proteins linked to the immune system, cell adhesion, blood vessel formation and known prostate cancer genes were associated with the future risk of developing prostate cancer, including aggressive disease, in a new study led by researchers at Oxford Population Health.
The findings reveal biological differences between men who later developed prostate cancer and those who did not and may help guide future studies aimed at identifying men at greater risk of the disease.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in